IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia

Simple item page
dc.contributor.authorClara Vásquez Velásquez
dc.contributor.authorGraciela Russomando
dc.contributor.authorEmilio E. Espínola
dc.contributor.authorZunilda Sánchez
dc.contributor.authorKota Mochizuki
dc.contributor.authorYelin Roca
dc.contributor.authorJimmy Revollo
dc.contributor.authorAngelica Guzman
dc.contributor.authorBenjamín Quiroga
dc.contributor.authorSusana Rios Morgan
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:52:45Z
dc.date.available2026-03-22T14:52:45Z
dc.date.issued2019
dc.descriptionCitaciones: 8
dc.description.abstractPlasma levels of IL-17A might be a bio-marker for detecting persistent infection of T. cruzi and its chronic inflammation.
dc.identifier.doi10.1371/journal.pntd.0007715
dc.identifier.urihttps://doi.org/10.1371/journal.pntd.0007715
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/49081
dc.language.isoen
dc.publisherPublic Library of Science
dc.relation.ispartofPLoS neglected tropical diseases
dc.sourceNagasaki University
dc.subjectTrypanosoma cruzi
dc.subjectBiomarker
dc.subjectNeglected tropical diseases
dc.subjectChagas disease
dc.subjectBiology
dc.subjectImmunology
dc.subjectVirology
dc.subjectMedicine
dc.subjectEnvironmental health
dc.titleIL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia
dc.typearticle

Files

Collections

Artículo Científico Publicado